CHRISTOPHER S. BOERNER Insider Trading $SGEN Seagen Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHRISTOPHER S. BOERNER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHRISTOPHER S. BOERNER. CHRISTOPHER S. BOERNER is EVP, Chief Commercial Officer in BRISTOL MYERS SQUIBB CO ($BMY) and EVP, Commercial in SEATTLE GENETICS INC /WA ($SGEN) and Executive Vice President, Comm in SEATTLE GENETICS INC /WA ($SGEN) and SVP, Commercial in SEATTLE GENETICS INC /WA ($SGEN).
CHRISTOPHER S. BOERNER in Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CHRISTOPHER S. BOERNER: Executive Vice President, Comm, EVP, Commercial, SVP, Commercial
Holdings: 72,358 shares
Current Value: $4,398,643
Latest Transaction: Aug 27 2014
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of CHRISTOPHER S. BOERNER in Seagen Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 27 2014 | SGEN | SEATTLE GENETICS I ... | BOERNER CHRISTOPHER S. | Executive Vice Pres ... | Option Exercise | A | 44.09 | 37,732 | 1,663,604 | 37,732 | |
| Aug 27 2014 | SGEN | SEATTLE GENETICS I ... | BOERNER CHRISTOPHER S. | Executive Vice Pres ... | Option Exercise | A | 44.09 | 2,268 | 99,996 | 2,268 | |
| Aug 27 2014 | SGEN | SEATTLE GENETICS I ... | BOERNER CHRISTOPHER S. | Executive Vice Pres ... | Grant | A | 0.00 | 16,000 | 0 | 72,358 | 56.4 K to 72.4 K (+28.39 %) |
| Aug 27 2014 | SGEN | SEATTLE GENETICS I ... | BOERNER CHRISTOPHER S. | Executive Vice Pres ... | Sell | S | 43.55 | 1,248 | 54,349 | 56,358 | 57.6 K to 56.4 K (-2.17 %) |
| Mar 07 2014 | SGEN | SEATTLE GENETICS I ... | BOERNER CHRISTOPHER S. | EVP, Commercial | Grant | A | 0.00 | 10,000 | 0 | 57,514 | 47.5 K to 57.5 K (+21.05 %) |
| Feb 25 2014 | SGEN | SEATTLE GENETICS I ... | BOERNER CHRISTOPHER S. | SVP, Commercial | Sell | S | 54.98 | 1,452 | 79,825 | 46,075 | 47.5 K to 46.1 K (-3.06 %) |
| Aug 21 2013 | SGEN | SEATTLE GENETICS I ... | BOERNER CHRISTOPHER S. | SVP, Commercial | Option Exercise | A | 41.04 | 32,564 | 1,336,427 | 32,564 | |
| Aug 21 2013 | SGEN | SEATTLE GENETICS I ... | BOERNER CHRISTOPHER S. | SVP, Commercial | Option Exercise | A | 41.04 | 2,436 | 99,973 | 2,436 | |
| Aug 21 2013 | SGEN | SEATTLE GENETICS I ... | BOERNER CHRISTOPHER S. | SVP, Commercial | Grant | A | 0.00 | 14,000 | 0 | 47,527 | 33.5 K to 47.5 K (+41.76 %) |
| Aug 21 2013 | SGEN | SEATTLE GENETICS I ... | BOERNER CHRISTOPHER S. | SVP, Commercial | Sell | S | 40.91 | 226 | 9,246 | 33,527 | 33.8 K to 33.5 K (-0.67 %) |
| Mar 19 2013 | SGEN | SEATTLE GENETICS I ... | BOERNER CHRISTOPHER S. | SVP, Commercial | Option Exercise | M | 15.10 | 8,500 | 128,350 | 17,988 | |
| Mar 19 2013 | SGEN | SEATTLE GENETICS I ... | BOERNER CHRISTOPHER S. | SVP, Commercial | Sell | S | 33.61 | 8,500 | 285,663 | 33,753 | 42.3 K to 33.8 K (-20.12 %) |
| Mar 19 2013 | SGEN | SEATTLE GENETICS I ... | BOERNER CHRISTOPHER S. | SVP, Commercial | Buy | M | 15.10 | 8,500 | 128,350 | 42,253 | 33.8 K to 42.3 K (+25.18 %) |
| Aug 22 2012 | SGEN | SEATTLE GENETICS I ... | BOERNER CHRISTOPHER S. | SVP, Commercial | Option Exercise | A | 26.10 | 27,348 | 713,783 | 27,348 | |
| Aug 22 2012 | SGEN | SEATTLE GENETICS I ... | BOERNER CHRISTOPHER S. | SVP, Commercial | Option Exercise | A | 26.10 | 2,652 | 69,217 | 2,652 | |
| Aug 22 2012 | SGEN | SEATTLE GENETICS I ... | BOERNER CHRISTOPHER S. | SVP, Commercial | Grant | A | 0.00 | 12,000 | 0 | 33,753 | 21.8 K to 33.8 K (+55.16 %) |
| Mar 05 2012 | SGEN | SEATTLE GENETICS I ... | BOERNER CHRISTOPHER S. | SVP, Commercial | Option Exercise | A | 18.46 | 36,057 | 665,612 | 36,057 | |
| Mar 05 2012 | SGEN | SEATTLE GENETICS I ... | BOERNER CHRISTOPHER S. | SVP, Commercial | Option Exercise | A | 18.46 | 3,943 | 72,788 | 3,943 | |
| Mar 05 2012 | SGEN | SEATTLE GENETICS I ... | BOERNER CHRISTOPHER S. | SVP, Commercial | Grant | A | 0.00 | 14,000 | 0 | 21,348 | 7.3 K to 21.3 K (+190.53 %) |
| Mar 05 2012 | SGEN | SEATTLE GENETICS I ... | BOERNER CHRISTOPHER S. | SVP, Commercial | Grant | A | 0.00 | 4,500 | 0 | 6,301 | 1.8 K to 6.3 K (+249.86 %) |
| Mar 05 2012 | SGEN | SEATTLE GENETICS I ... | BOERNER CHRISTOPHER S. | SVP, Commercial | Grant | A | 0.00 | 819 | 0 | 1,801 | 982 to 1.8 K (+83.40 %) |
Page: 1